Helixtalk - Rosalind Franklin University's College Of Pharmacy Podcast
076 - The New Move: Treating Tardive Dyskinesia
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:36:06
- Mas informaciones
Informações:
Sinopsis
In this episode, we discuss two new agents (valbenazine and deutetrabenazine) -- the first of their kind to receive FDA approval to manage tardive dyskinesia most commonly associated with antipsychotic use.